Inorganic arsenic is a toxic naturally occurring element in soil and water in many regions of the US including the Midwest. Prostate cancer is the second most common type of cancer in men in Iowa, surpassed only by nonmelanotic skin cancer. Epidemiology studies have evaluated arsenic exposure from drinking water and prostate cancer, but most have focused on high-level exposures outside the US. As drinking water from groundwater sources is a major source of arsenic exposure, we conducted an ecologic study to evaluate prostate cancer and arsenic in drinking water from public water sources and private wells in Iowa, where exposure levels are low, but duration of exposure can be long.
Introduction
Arsenic is a naturally occurring element in the earth's crust and has anthropogenic uses, including wood treatment, pigments, and semiconductor processing (IARC, 2009) . The primary source of arsenic exposure is drinking water (Chung et al., 2014; Smith et al., 1992) . In the Midwest of the United States including Northern Iowa, soils, composed of glacial sediments that migrated 16,000-12,000 years ago during the late Wisconsin-aged glacial drift, contain higher concentrations of arsenic (Erickson and Barnes, 2005) . Arsenic easily migrates from contaminated soil into ground water depending on geochemical conditions (Erickson and Barnes, 2005; Michael, 2013) . Public water systems are regulated with a current drinking water standard for arsenic at 10 ppb under the Safe Drinking Water Act (EPA, 2009 ), but private wells are not regulated or monitored.
Arsenic is classified as a group 1 carcinogen by IARC as there are sufficient experimental and epidemiologic studies supporting causation of skin, bladder, and lung cancers (IARC, 2009) . As summarized in the IARC monograph, potential mechanisms of arsenic carcinogenesis may be through oxidative DNA damage, gene amplification, aneuploidization (by spindle disturbance), inhibition of DNA repair enzymes, and changes in DNA methylation and histone modifications, leading to altered gene expressions and changes in cell differentiation, proliferation, and response to signaling pathways (IARC, 2009) . Prostate cancer has also been reported to be positively associated with arsenic exposure (IARC, 2009) . Several epidemiologic studies of populations in Taiwan, Australia, Europe, Chile or the US reported increasing mortality or incidence of prostate cancer with arsenic exposure (Bardach et al., 2015; Brown et al., 2002; Bulka et al., 2016; Chen and Wang, 1990; Chen et al., 1988; Garcia-Esquinas et al., 2013; Gunduz et al., 2015; Hinwood et al., 1999; Lewis et al., 1999; Nunez et al., 2016; Rivara et al., 1997; Wu et al., 1989; Yang et al., 2008) . Some measured arsenic levels in urine (Garcia-Esquinas et al., 2013) or levels in top soil (Nunez et al., 2016) , but the majority focused on drinking water as source of arsenic exposure. Of these, most evaluated the association of high-level arsenic exposure and prostate cancer and all observed a positive association. For example, prostate cancer mortality was found to increase with exposure to arsenic up to 2500 ppb in Taiwan (Yang et al., 2008) . Reports on the effects of low-level arsenic exposure on prostate cancer are sparse. One study from Denmark did not observe an association of lowlevel arsenic (0.05-25.5 ppb, mean 1.2 ppb) and prostate cancer (Baastrup et al., 2008) . One recent ecologic study reported on the effect of low-level arsenic exposure and showed a 5-10% increased incidence of prostate cancer from arsenic exposure in a dose-response manner in Illinois counties with arsenic levels ranging from 0.33 to 16.23 ppb in public drinking water (Bulka et al., 2016) . This finding and the fact that prostate cancer has the highest cancer incidence in men in the US (excluding non-melanotic skin cancer) (Brawley, 2012; IARC, 2009) , justifies further analysis of the risks of low-level arsenic exposure from drinking water and prostate cancer. We therefore conducted an ecologic study to investigate the association between low-level arsenic exposure from drinking water and the incidence of prostate cancer in Iowa, accounting for both public water sources and private water wells as source of drinking water.
Methods

Arsenic exposure data
Arsenic testing data from 1994 to 2003 from 723 public water systems in 97 of the 99 Iowa counties were obtained from the Iowa Safe Drinking Water Information System. Two counties were excluded because they did not have their own public water stations and therefore county-specific arsenic data were not available. Two different studies, the Iowa Community Private Well Study (ICPWS, 2002 (ICPWS, -2003 and the Iowa Statewide Rural Well Water Survey Phase 2 (SWRL2, 2006 (SWRL2, -2008 , with water samples analyzed by the Iowa State Hygienic Laboratory, were combined and provided arsenic concentration data in water samples from 709 private wells in 89 counties (CHEEC, 2009; IDNR, 2004) . In the ICPWS, 103 wells were randomly selected from 50 counties, and 133 wells were selected from 15 counties with assumed higher risk of contamination. In SWRL2, 116 wells, which were included in the original SWRL (1988 SWRL ( -1989 study and still active currently, and additional 357 randomly selected wells were sampled (https://cheec.uiowa.edu/swrl2). Although the period of the Iowa Statewide Rural Well Water Survey was outside the 1994-2003 period, it was utilized in this study because a temporal stability of arsenic levels in ground water has been reported in studies from Argentina and Nevada (Concha et al., 2006; Steinmaus et al., 2005) . All datasets were obtained from the Center for Health Effects of Environmental Contamination at the University of Iowa (https://cheec.uiowa.edu/ cooperative-projects). There were no active private wells and therefore no well water data in 10 counties. Thus arsenic data for both public water systems and private wells were available for 87 of the 99 counties in Iowa. County arsenic levels in the drinking water were calculated from average arsenic levels in both municipal water and private well water with weighting by the percentages of county populations who use municipal water and private well water. If the concentration was lower than the limit of detection (LOD), half of LOD was assigned as the level (Lopez-Carrillo et al., 2010) . LODs were 1 ppb for private wells, and varied from 0.01 to 10 ppb for public water systems. Iowa counties were categorized into three groups by tertiles of average arsenic level in the drinking water: low exposure (1.08-2.06 ppb), medium exposure (2.07-2.98 ppb), and high exposure groups (2.99-18.6 ppb).
Prostate cancer incidence data
Data of all new prostate cancer cases in the state of Iowa between 2009 and 2013 were obtained from the Surveillance, Epidemiology, and End Results (SEER) program via SEER*Stat version 8.3. This database provided the number of observed cases and the population distribution by age-specific categories for each county ( Table 1) . As people of other races accounted for 5.5% of population in Iowa, they were excluded and only white males were included in this study. Aggressive prostate cancer was identified as distant stage at diagnosis and/or poorly differentiated (Gleason score ≥ 7) or undifferentiated tumor grades using this software.
Covariates data
Percentages of the population that obtain their drinking water from a public water system or private well by county were obtained from Water Use Data for the Nation as part of National Water Information System (NWIS) for 1995 and 2000. Poverty rate for 2009-2013 was obtained from the Small Area Income and Poverty Estimates (SAIPE) of the Census Bureau and used as a proxy measure for socioeconomic status, which is related to cancer patterns (Singh et al., 2003) . Poverty rate indicates the percentage of population below the federal poverty level based on household size and income (Proctor et al., 2016) . Information on general cancer risk factors, including tobacco smoking rate (current smoker), binge drinking rate (5 or more drinks an occasion during the past 30 days), and obesity rate (BMI ≥ 30) in each county for 1997-2013 was acquired from the Iowa Behavioral Risk Factor Surveillance System (BRFSS) through a research agreement with the Iowa Department of Public Health (Park et al., 2006; Samanic et al., 2004; Thun et al., 1997; Yun et al., 2005) . These data were also restricted to the white male population at the county level. In addition, county-level pesticide-use density was included as a proxy of pesticide exposure (Reynolds et al., 2005) , calculated by annual pesticide use divided by land area. Pesticide use data and county land area were obtained from the U.S. Geologic Survey and U.S. Department of Agriculture (USDA, 2004; USGS, 2017). T. Roh et al. Environmental Research 159 (2017) 338-343 
Statistical analysis
The standardized incidence ratio (SIR) was calculated by dividing the number of observed cases by the number of expected cases of prostate cancer for each county. The expected number of prostate cancer cases for each county was calculated using indirect standardization, based on the age-specific prostate cancer rates in 10-year age groups (30-39, 40-49, 50-59, 60-69, 70-79, and 80+; A spatial Poisson regression model analysis was used to evaluate the association between arsenic exposure and the incidence of prostate cancer (Cleophas and Zwinderman, 2016) . The unit of analysis for this study was the county. Arsenic levels were trichotomized based on tertiles of arsenic concentration in drinking water. Poverty, tobacco smoking, binge drinking, and obesity rates at county level were included as covariates ( Table 2 ). The log of the expected number of cases was used as an offset term. The Chi-square statistic was used to determine the statistical significance. Further analysis focusing on aggressive prostate cancer was performed as an indirect manner to control the potential confounding associated with prostate cancer screening. Spatial autocorrelation is reported to occur frequently in ecological data because observations from nearby locations are often more similar than would be expected on a random basis (Kissling and Carl, 2008) . Spatial effect is represented by using the latitude and longitude of the central point of each county. Moran's I statistic was calculated to test whether there was spatial autocorrelation among neighboring areas (Anselin, 1995; Kissling and Carl, 2008) . Since a majority (98.5%) of the prostate cancer patients were 50 years old or older (Table 1) , subjects in this age range were analyzed additionally to test for possible early onset cancers. SAS (version 9.4, Cary, NC) was used for all statistical analyses. Statistical significance was declared when the p-value was less than 0.05.
Geographic mapping
Geographic data for boundaries of counties of the state of Iowa were obtained from the National Resources Geographic Information System of the Iowa Department of Natural Resources. Maps were created to illustrate the arsenic level in the drinking water and SIR categorized into tertiles at the county level. All geographic mapping was conducted using ArcGIS (version 10.3, ESRI, Redlands, CA).
Results
The spatial patterns of arsenic levels in drinking water and SIRs of prostate cancer in Iowa at the county level are shown in Figs. 1 and 2 , respectively. The SIR ranged from 0.64 in the lowest to 1.634 in the highest incidence county. Average arsenic levels in drinking water ranged from 1.08 to 18.6 ppb, although only 3 counties surpassed the current action level of 10 ppb (until January 2006, the effective EPA standard for arsenic in drinking water was 50 ppb).
There were 9947 newly diagnosed prostate cancer cases in Iowa during [2009] [2010] [2011] [2012] [2013] (Table 1) . While there were no prostate cancers among white males aged under 30, as expected, over 98% of prostate cancers were diagnosed at age 50 and older.
In our crude model, the risk of prostate cancer significantly increased by 9% and 18% in the county groups with the medium and high range of arsenic levels in drinking water, respectively, compared to the , 2000, 2012, 2016) . county group with low range of arsenic levels (Table 3) . After adjusting for poverty, smoking, drinking and obesity, the risk of prostate cancer significantly increased by 23% and 28% in the medium and high groups, respectively, compared to the low group. Further analysis only focusing on aggressive prostate cancers also showed increased incidence of prostate cancer with arsenic exposure from drinking water by 11% and 32% in medium and high arsenic counties, and by 20% and 36%, respectively, after adjusting for covariates (Table 4) . Once again in all models, the incidence of prostate cancer increased between county groups with increasing arsenic levels and demonstrated a dose-dependent relationship.
An analysis limited to patients aged 50 and older at diagnosis (results not shown) were not appreciably different from risk ratios for all ages shown in Tables 3 and 4.
Discussion
In this ecologic study, a positive association between arsenic exposure from drinking water and prostate cancer was found using spatial Poisson regression modeling. Prostate cancer incidences were significantly higher in counties with higher levels of arsenic in public and private drinking water in a dose-dependent manner. A stronger association was observed after adjusting for demographic and risk factor such as poverty, smoking, drinking, and obesity for each county. These results are consistent with previous studies that showed positive associations of arsenic exposure and prostate cancer (Bulka et al., 2016; Hinwood et al., 1999; Hsu et al., 2013) .
In this study, arsenic levels for both public and private drinking water were included in the analysis. As private wells are not regulated, water analysis data were limited or not available in a previous study (Bulka et al., 2016) . However, two sources of arsenic testing data were available for Iowa private wells. Most private wells were sampled only once or twice during the study periods. Since no temporal change of arsenic level in groundwater was observed in the prior studies and urine arsenic levels were relatively constant over a 10-year period in a population exposed to similar arsenic levels as in Iowa, the use of these data seems appropriate (Concha et al., 2006; Navas-Acien et al., 2009; Steinmaus et al., 2005) . Water sample data from 709 private wells representing 89 of the 99 counties in Iowa were available. Most of these wells were randomly selected. Although this represents only a small fraction of the total number of private wells used for drinking water, these data provide a first, state-wide analysis of arsenic levels in private well water in Iowa. After excluding two additional counties that had no arsenic data for public water since they used water supplied from neighboring counties, a total of 87 counties are included in this study, providing a nearly complete coverage of the state.
Most studies on the health effects of arsenic exposure from water have been conducted in countries with high arsenic levels of up to 2500 ppb, such as Taiwan, Bangladesh, and Chile (Argos et al., 2014; Marshall et al., 2007; Yang et al., 2008) . There are a limited number of studies conducted in locations with low-level arsenic exposure. In a Utah study, the risk of death from prostate cancer was elevated by 45% from exposure to drinking water arsenic ranging from 14 to 166 ppb (Lewis et al., 1999) . A prospective cohort study observed a 3.3 times increased mortality for prostate cancer by comparing the groups of the 80th and 20th percentile of urine arsenic level that ranged from < 10 to 61 ppb in American Indians from Arizona, Oklahoma, North Dakota, T. Roh et al. Environmental Research 159 (2017) 338-343 and South Dakota (Garcia-Esquinas et al., 2013) . Recently, a study conducted in Illinois, a Midwest state with low arsenic levels ranging from 0.33 to 16.23 ppb, showed a relationship between arsenic exposure from public drinking water with prostate cancer (Bulka et al., 2016) . As the range of average county arsenic levels in drinking water from public sources and private wells in Iowa was 1.08-18.6 ppb, our arsenic levels were similar to those in the Illinois study and we found a similar association with prostate cancer.
The mechanism of arsenic carcinogenesis may be related to changes in the expression of various genes (IARC, 2009 ). The biological plausibility of the increase in risk of prostate cancer by arsenic exposure is provided by experimental studies. Based on these studies several mechanisms of arsenic-induction of prostate cancer have been proposed including overexpression of matrix metalloproteinase-9, heme oxygenase-1, and ras, the decreased expression of thrombospondin, and the induction of acquired androgen independence (Benbrahim-Tallaa and Waalkes, 2008; Benbrahim-Tallaa et al., 2005 Witz, 2008) . In a recent study, the alteration of stromal TGFβ signaling by arsenic exposure was shown to be related to progression of prostate cancer (Shearer et al., 2016) .
We considered a latency period between exposure to arsenic and the incidence of prostate cancer as we included an exposure period that was between 1994 and 2003, while incident prostate cancers diagnosed between 2009 and 2013. The latency period for peak occurrence of increased cancer mortality after arsenic exposure can be very long, on average 20-25 years, but even longer periods of over 50 years as well as increases of childhood cancers due to arsenic exposure, suggesting short latency times, have been summarized in a recent review (Naujokas et al., 2013) . A minimal latency period of 5 years, as reported and used for other exposures and cancer types (Farioli et al., 2013; Ferreccio et al., 2013; Melak et al., 2014; Steinmaus et al., 2013) seemed therefore justified. It should be pointed out, however, that according to those studies the increased risk for adverse health effects due to arsenic exposure may continue for a lifetime, further highlighting the urgent need for more in-depth, data-driven arsenic risk assessment.
Risk factors and potential confounding factors were considered and adjusted for in the analyses. As the risk of prostate cancer increases significantly in older ages, the effects of age were excluded by using indirect standardization. Racial disparities were also excluded by focusing only on white males. Smoking, binge drinking, and obesity were considered, although these factors showed an inverse relationship to arsenic levels. The percentage of population below the federal poverty level was included as a proxy of socioeconomic status (SES) as high SES is linked to a lower rate of uninsured and better access to health care including PSA screening (Adler and Newman, 2002; Ross et al., 2006; Rundle et al., 2013) . The percentage of population without health insurance was correlated with poverty (Pearson's correlation coefficient = 0.61) and therefore not included. In addition, county-level pesticide density was included as a proxy of pesticide exposure, as pesticide exposure is known to increase the risk for prostate cancer (Alavanja et al., 2003; Band et al., 2011; Cockburn et al., 2011; Koutros et al., 2013) . The adjustment for these risk factors resulted in higher risk ratios of 10-15% compared to the crude rate. Performing the analyzes using all ages or only those above 50 did not show significant differences, suggesting that arsenic exposure may not cause an earlier onset of prostate cancer. Potential confounding associated with prostate cancer screening was evaluated by performing restricted analyses of only aggressive prostate cancer cases. The effect was negligible for the medium arsenic group, but increased the RR by 14% and 8% for the crude and adjusted model, respectively, for the high arsenic group. This interesting finding may imply that arsenic in drinking water could possibly act in accelerating the progression of prostate cancer. This possibility needs to be further investigated using prostate cancer mortality data.
There are some limitations in this study. First, there could be differential misclassification of arsenic exposure in this study (Smith et al., 2016) . Individual differences in the consumption of water and the consumption of other sources of water such as nonresidential water, bottled water, and other beverages and the use of arsenic-specific filtration system were not considered as such information was not available. Given that use of bottled and filtered water could reduce the arsenic exposure, analysis of individual levels of arsenic and methylated arsenic in urine would provide better data about current exposure (Concha et al., 2006) , but could misclassify exposure levels from earlier years. High LODs with a high percentage of samples below the LOD could also lead to exposure misclassification. For example, any sample with a LOD of 10 ppb was assigned a LOD of 10/2 or 5 ppb, automatically placing it in the high exposure group. However, all private water wells had LODs of 1 ppb and the number of public water samples below a LOD of 10 ppb was small (12%) and further reduced when multiple measurements of the same water source on the same day, month or year were averaged. In addition, an analysis of data after excluding all public water samples with LODs over 1 ppb still showed the significant dose-response relationship between arsenic exposure and prostate cancer, with the risk decreased by 6-10% compared to the current results. This underscores the robustness of the findings. Second, other risk factors for prostate cancer including family history of prostate cancer, hormonal, and other genetic factors could not be considered because those data were not available (Alberti, 2010; Hebert et al., 1998; Rowlands et al., 2009) . Since Iowans have a high degree of German and Scandinavian ancestry, future studies could investigate the influence of inherited susceptibility by comparing Iowa with other states. Third, African-Americans have a higher risk of prostate cancer, but because of the small number of African-Americans in Iowa, the study was restricted to whites. Last, this study is an ecological study conducted with county-level data because individual-level data were not available. Individual-level analysis would be required for a stronger conclusion with better exposure assessment and consideration of risk factors (Greenland, 2001) .
Despite these limitations, we observed a significantly increased risk of prostate cancer in a dose-response manner as arsenic concentration in the drinking water increased even at low levels. Importantly, this study allows the identification of "hot spot" counties with higher levels of arsenic contamination and higher incidences of prostate cancer for further study and for community-level intervention strategies. As our low-level arsenic was even lower than the current regulatory level of 10 ppb and showed an increased risk of prostate cancer, arsenic awareness initiatives like for example the one in New Jersey (http://blogs.ei. columbia.edu/2016/06/16/get-the-facts-arsenic-in-new-jersey-wellwater/) should be implemented in states with private wells that may contain arsenic to inform the public. In addition, stricter regulations should be discussed if this result is replicated in future studies including those with individual-level analysis.
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